Covered recipient · General Payments record
MARCUS C STOKES
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2018–2024
$943.05
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $675.04 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Reapplix Inc. | $517.51 | 2 |
| ABBVIE INC. | $141.29 | 16 |
| Solventum Corporation | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168067 | CMS |
| ABBVIE INC. | $17.13 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168069 | CMS |
| ABBVIE INC. | $7.76 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168071 | CMS |
| ABBVIE INC. | $2.19 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168073 | CMS |
| ABBVIE INC. | $11.28 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168075 | CMS |
| ABBVIE INC. | $9.08 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168077 | CMS |
| ABBVIE INC. | $8.97 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168079 | CMS |
| ABBVIE INC. | $6.72 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168081 | CMS |
| ABBVIE INC. | $9.65 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168083 | CMS |
| ABBVIE INC. | $10.07 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168085 | CMS |
| ABBVIE INC. | $6.44 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168087 | CMS |
| ABBVIE INC. | $13.63 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168089 | CMS |
| ABBVIE INC. | $7.80 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168091 | CMS |
| ABBVIE INC. | $4.29 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168093 | CMS |
| ABBVIE INC. | $9.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168095 | CMS |
| ABBVIE INC. | $7.12 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106168097 | CMS |
| Reapplix Inc. | $455.88 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144460136 | CMS |
| Reapplix Inc. | $61.63 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144460150 | CMS |
| Solventum Corporation | $16.24 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144088539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.